argenx SE
+$4.33 (+1.42%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell argenx SE and other ETFs, options, and stocks.
About ARGX
argenx SE is a clinical-stage biotechnology company, which engages in the development of antibody-based therapies for the treatment of autoimmune diseases and cancer. Its products include ARGX-113 for the treatment of autoimmune disease myasthenia gravis and ARGX-110 for the treatment of hematological cancer acute myeloid leukemia.
CEO
Tim van Hauwermeiren
Employees
336
Headquarters
Breda, Noord-Brabant
Founded
2008
ARGX Key Statistics
Market Cap
15.73B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
167.02K
High Today
$311.28
Low Today
$303.03
Open Price
$307.30
Volume
144.19K
52 Week High
$382.15
52 Week Low
$212.66
Analyst Ratings
63%
of 24 ratings
Buy
62.5%
Hold
37.5%
Sell
0%
ARGX Earnings
-$4.21
-$2.15
-$0.08
$1.98
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
-$3.63 per share
Actual
$1.98 per share